|
|
|
Volumn 25, Issue 4 SUPPL., 1998, Pages 2-10
|
|
An update on North American randomized studies in non-small cell lung cancer
a a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CISPLATIN;
DOCETAXEL;
ETOPOSIDE;
FLUOROURACIL;
FOLINIC ACID;
GEMCITABINE;
IFOSFAMIDE;
IRINOTECAN;
NAVELBINE;
PACLITAXEL;
BLOOD TOXICITY;
CANCER CHEMOTHERAPY;
CANCER PALLIATIVE THERAPY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CLINICAL TRIAL;
HUMAN;
LUNG NON SMALL CELL CANCER;
MUCOSA INFLAMMATION;
MYALGIA;
NEUROPATHY;
PRIORITY JOURNAL;
QUALITY OF LIFE;
REVIEW;
SURVIVAL TIME;
UNITED STATES;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
COMBINED MODALITY THERAPY;
HUMANS;
LUNG NEOPLASMS;
NORTH AMERICA;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 0031949039
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (42)
|
|
References (31)
|